Company research / BLGO

BIOLARGO, INC. (BLGO)

CIK 0000880242 · OTC · Chemicals & Allied Products

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, BIOLARGO, INC. reported revenue of $7.76M. Revenue fell 56.3% from the prior annual period.

Key ratios (year ended 2025-12-31)

43.9%
Gross margin
-191.3%
Operating margin
-195.6%
Net margin
-375.8%
Return on year-end equity
-56.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.